UBS Group AG current report, Q3 FY2020

UBS Group AG Third Quarter 2020 Filing Summary

Business Context and Reporting Period

This Form 6-K reports the unaudited consolidated financial results for UBS Group AG for the quarter ended September 30, 2020. The reporting period reflects continued operations during the COVID-19 pandemic, with over 95% of staff working remotely. Key strategic developments include the sale of a majority stake in Fondcenter AG and the establishment of a strategic investment banking partnership with Banco do Brasil.

Key Financial Metrics

Metric (USD Million) Q3 2020 Q3 2019 YTD 2020 YTD 2019
Operating Income 8,935 7,088 24,273 21,838
Operating Expenses 6,357 5,743 18,103 17,188
Operating Profit Before Tax 2,578 1,345 6,169 4,650
Net Profit Attributable to Shareholders 2,093 1,049 4,921 3,582
Diluted EPS (USD) 0.56 0.28 1.33 0.95
Return on Equity (%) 14.4 7.7 11.5 8.9
Cost/Income Ratio (%) 70.4 80.6 72.7 78.5
Total Assets (USD Billion) 1,065.2 973.1 1,065.2 973.1
Common Equity Tier 1 (CET1) Capital Ratio (%) 13.5 13.1 13.5 13.1
Liquidity Coverage Ratio (%) 154 138 154 138

Material Changes vs. Prior Period

  • Profitability Surge: Net profit attributable to shareholders increased 99% year-over-year to USD 2.09 billion, driven by higher operating income and a lower effective tax rate (18.8% vs 21.9%).
  • One-Time Gains: Operating income included a USD 631 million post-tax gain from the sale of a 51.2% stake in Fondcenter AG and a USD 215 million gain from the sale of intellectual property rights related to the Bloomberg Commodity Index.
  • Expense Acceleration: Personnel expenses increased by USD 644 million, largely due to a USD 359 million acceleration of expense recognition related to modified deferred compensation awards.
  • Credit Losses: Net credit loss expenses were USD 89 million, significantly lower than the USD 272 million recorded in Q2 2020, though higher than the USD 38 million in Q3 2019. A USD 59 million expense was recognized in Personal & Corporate Banking related to a fraud case at a commodity trade finance counterparty.
  • Capital Position: CET1 capital increased to USD 38.2 billion, and the CET1 ratio rose to 13.5% due to a decrease in risk-weighted assets (RWA) to USD 283.1 billion.

Guidance, Outlook, and Risks

  • Capital Returns: UBS has established a USD 1.5 billion capital reserve for potential share repurchases, expecting to resume buybacks in 2021. A second tranche of the 2019 dividend (USD 0.365 per share) is proposed for an extraordinary general meeting in November 2020.
  • Outlook: Management expects credit loss expenses in Q4 2020 to remain markedly lower than in the first half of the year. However, renewed uncertainty regarding COVID-19 cases and geopolitical tensions may lead to market volatility.
  • Regulatory Constraints: Capital distributions and share repurchases remain restricted in the US (Federal Reserve) and Europe (ECB) through the end of 2020.
  • Risks: Significant litigation and regulatory matters remain, including cross-border wealth management inquiries (France, Belgium), RMBS claims, and benchmark rate manipulation proceedings. Management estimates a potential capital loss of USD 4.3 billion over a 12-month horizon from these operational risk categories.

Key Facts for Investor Verification

  • Non-Recurring Items: Verify the impact of the USD 631 million Fondcenter gain and USD 215 million IP sale gain on core operating performance.
  • Compensation Adjustments: Confirm the USD 359 million expense acceleration related to deferred compensation modifications and its impact on future quarters.
  • Capital Reserve: Note the USD 1.5 billion capital reserve set aside for share repurchases, which reduces the reported CET1 ratio by 70 basis points if excluded.
  • Regulatory Restrictions: Monitor the timeline for the lifting of capital distribution restrictions in the US and EU, currently set for January 1, 2021.
  • Leadership Transition: Ralph Hamers is scheduled to succeed Sergio Ermotti as Group CEO on November 1, 2020.